DiaMedica Therapeutics Inc.

Annual 10-K Item 1C cybersecurity disclosure describing the registrant's cybersecurity risk management, strategy, and governance program, including board oversight, CFO day-to-day responsibility, employee training, outsourced IT security vendor, and continuous monitoring. The filer states that, to date, it is not aware of any cybersecurity threats that have materially affected or are reasonably likely to materially affect its business strategy, results of operations, or financial condition. No specific incident is disclosed.